Angioedema and Waldenström macroglobulinemia

  1. Méndez-Alcalde, J. D. 1
  2. Martín-Armentia, B. 1
  3. Armentia-Medina, A. 1
  4. Cabrerizo-Ballesteros, S. 2
  5. San-Miguel-Hernández, A. 3
  6. García-Villamuza, Y. 2
  7. Alonso-Alonso, J. M. 4
  1. 1 Sanidad de Castilla y León – SACYL. Hospital Universitario Río Hortega. Unidad de Alergología. Valladolid, España
  2. 2 Sanidad de Castilla y León – SACYL. Complejo Asistencial Universitario de Palencia. Unidad de Alergología. Palencia, España
  3. 3 Sanidad de Castilla y León – SACYL. Hospital Universitario Río Hortega. Servicio de Análisis Clínicos. Valladolid, España
  4. 4 Sanidad de Castilla y León – SACYL. Complejo Asistencial Universitario de Palencia. Servicio de Hematología. Palencia, España
Montrer des affiliations +
Revue:
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios

ISSN: 0304-4858,  2173-2302

Année de publication: 2021

Volumen: 118

Número: 4

Pages: 262-265

Type: Article

DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios

Résumé

We describe a patient with angioedema diagnosed with Waldenström's macroglobulinemia in complete remission after adequate therapy. In this type of patients, lymphoproliferative diseases must be taken into account in the differential diagnosis of angioedema.

Références bibliographiques

  • Agostoni A, Aygören-Pürsün E, Binkley KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Aller-gy Clin Immunol. 2004; 114:S51-131.
  • Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev. 2008; 8:156-9.
  • Frigas E. Angioedema with acquired deficiency of C1 inhibitor: a constellation of syndromes. Mayo Clin Proc. 1989; 64:1269-75.
  • Zuraw B. Clinical practice: hereditary angioedema. N Engl J Med. 2008; 359:1027–36.
  • Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol. 2010;6(1):14.
  • Branellec A, Bouillet L, Javaud N, Mekinian A, Boccon-Gibod I, Blanchard-Delaunay C, et al. Acquired C1-inhibitor deficiency: 7 patients treated with rituximab. J Clin Immunol. 2012; 32; 5:936–41.
  • Lewkonia RM, Pineo GF. Angioedema-like skin lesions associated with lymphoproliferative disease. Can Med Assoc J. 1982; 127; 9:867-8.
  • Casali P, Bozzini P, Pioltella P, Invernizzi F, Zanus-si C. Acquired C1 inhibitor deficiency in essential cryoglobulinemia and macroglobulinemia. Acta Haematol. 1978; 59:277-84.
  • Richardson SG, Clarke C, Gasson GB. Lymphocytic lymphoma and acquired C1 esterase inhibitor deficiency. Br J Dermatol. 1989; 120:121-4.
  • Welwood J, Taylor K, Wright S, Bentley M, Eliadis P. Angioedema in the emergency department: a presentation of lymphoma. Emerg Med. 2001; 13: 465-8.
  • Khanfar A. Trikha A. Bonds A, Jana B. Angioedema with normal C1q and C1 inhibitor: an atypical presentation of Waldenström macroglobulinemia. Int J Hematol. 2013; 97:654–656.
  • Zegers IH, Aaldering KN, Nieuwhof CM, Schouten HC. Non-myeloablative allogeneic stem cell transplantation: a new treatment option for acquired angioedema?. Neth J Med. 2015; 73; 8: 383-5.
La source de données: Dialnet